English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  52681991    在线人数 :  918
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"yu yun shao"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 46-55 / 113 (共12页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2020-04-10T12:16:10Z Survival following surgery with or without adjuvant chemotherapy for stage I-IIIA non-small cell lung cancer: An East Asian population-based study Lin Z.-Z.; Shau W.-Y.; YU-YUN SHAO; Yang Y.-Y.; Kuo R.N.-C.; Yang J.C.-H.; Laie M.-S.
臺大學術典藏 2020-04-10T12:16:10Z Dissimilar immunohistochemical expression of ERK and AKT between paired biopsy and hepatectomy tissues of hepatocellular carcinoma Cheng A.-L.; YU-YUN SHAO; Chen C.-L.; Ho M.-C.; Huang C.-C.; Tu H.-C.; Hsu C.-H.
臺大學術典藏 2020-04-10T12:16:10Z Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer Yeh K.-H.; Cheng A.-L.; Lin Y.-L.; Hsu C.; Cheng W.-F.; Hsu C.-H.; YU-YUN SHAO; Lu L.-C.
臺大學術典藏 2020-04-10T12:16:10Z Serum insulin-like growth factor-1 levels predict outcomes of patients with advanced hepatocellular carcinoma receiving antiangiogenic therapy YU-YUN SHAO; Huang C.-C.; Lin S.-D.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:09Z Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study Hsu C.; Cheng A.-L.; Jin K.; Hsu C.-H.; Kang Y.K.; Yang T.-S.; Shun C.-T.; YU-YUN SHAO; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.
臺大學術典藏 2020-04-10T12:16:09Z Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma Kuo R.N.C.; Lin Z.-Z.; Yeh Y.-C.; Shau W.-Y.; Hsu C.-H.; Cheng A.-L.; Lai M.-S.; Lu L.-C.; YU-YUN SHAO
臺大學術典藏 2020-04-10T12:16:09Z Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer YU-YUN SHAO; Shau W.-Y.; Lin Z.-Z.; Chen H.-M.; Kuo R.; Yang J.C.-H.; Lai M.-S.
臺大學術典藏 2020-04-10T12:16:09Z The germline BIM deletion polymorphism is not associated with the treatment efficacy of sorafenib in patients with advanced hepatocellular carcinoma Chang Y.-L.; YU-YUN SHAO; Huang C.-Y.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:08Z β-Catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma Cheng A.-L.; Hsu C.-H.; Lu L.-C.;Yu-Yun Shao;Lee Y.-H.;Hsieh M.-S.;Hsiao C.-H.;Lin H.-H.;Kao H.-F.;Ma Y.-Y.;Yen F.-C.;Cheng A.-L.;Hsu C.-H.; Lu L.-C.; YU-YUN SHAO; Lee Y.-H.; Hsieh M.-S.; Hsiao C.-H.; Lin H.-H.; Kao H.-F.; Ma Y.-Y.; Yen F.-C.
臺大學術典藏 2020-04-10T12:16:08Z Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size Lin Z.-Z.; Shau W.-Y.; Hsu C.; YU-YUN SHAO; Yeh Y.-C.; Kuo R.N.-C.; Hsu C.-H.; Yang J.C.-H.; Cheng A.-L.; Lai M.-S.

显示项目 46-55 / 113 (共12页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目